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ABSTRACT 
This experimental study aimed to investigate the protective effect of a bioflavonoid, hesperidin (HP), on formal-
dehyde (FA)-related pathophysiological and behavioral outcomes in pregnant rats and developmental aspects in 
their offspring. Female Wistar rats were subjected to perigestational exposure to FA (2 mg/kg/day per os) with a 
concomitant treatment with HP (50 mg/kg/day per os). Pregnant rats were weighed throughout gestation and tested 
in two behavioral paradigms (elevated plus-maze and open field) at gestational days (GD) 1, 10 and 19 to evaluate 
the anxiety-like behavior and locomotive alterations. Another subset of rats was decapitated at GD19 to determine 
the hematological profile along with cortisol, 17β-estradiol, and progesterone plasma levels. Reproductive and 
fetal measures and observations were also performed to check for developmental deformities. Significant body 
weight loss, hemato-immune decline, hormonal changes, anxiety and lethargy signs, locomotor disabilities, repro-
ductive failure and fetal weight decrease were observed in FA-exposed rats. Treatment with HP alleviated the 
reproductive and fetal weight defects. Its behavioral benefits were only seen at GD1 and 10. This flavanone ame-
liorated some hematological parameters, decreased cortisol levels and increased 17β-estradiol rates. A potential 
preventive impact of HP was found against FA toxicity in pregnant rats. 
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INTRODUCTION 
Formaldehyde (FA) is an organic com-
pound that naturally occurs in the form of a 
colorless gas. Its high toxicity and tissue-ne-
crotic effects regarding various organs have 
been neatly reported in experimental animals 
a long time ago (Fischer, 1905). Due to its 
multiple industrial applications, FA is readily 
inhaled and/or ingested by human beings who 
can develop a wide range of pathophysiologi-
cal symptoms depending on the exposure du-
ration (Kim et al., 2011). Over the last few 
decades, a particular attention has been paid 
to reproductive and developmental outcomes 
among pregnant women who were exposed to 
amounts of FA high enough to cause both ma-
ternal and fetal defects, such as spontaneous 
abortion, premature birth, and congenital mal-
formations (Duong et al., 2011). However, 
although FA is considered a toxic compound 
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for the offspring in utero, there is currently lit-
tle evidence describing the association of 
these fetotoxic aspects with the maternal 
physiological alterations. FA is transmitted to 
the fetus through the placenta following ma-
ternal exposure, and its adverse effects on the 
fetal growth processes may be related to the 
degree of injuries it causes to the maternal or-
ganism (Katakura et al., 1993). It was re-
ported that FA inhalation at 20-40 ppm in 
Sprague-Dawley rats on gestational days 
(GD) 6-20 resulted in a significant reduction 
in weight gain in both dams and fetuses 
(Saillenfait et al., 1989). Another study in the 
same animal model has indicated that FA in-
halation at a range of 2-10 ppm on GD6-15 
affected the maternal body weight along with 
a slight impact on fetal weights and ossifica-
tion of the pubic and ischial bones (Martin, 
1990). 
Earlier studies have also highlighted that 
FA exposure may lead to neurobehavioral and 
hemato-immunologic disturbances. For in-
stance, Kilburn et al. (1985) have provided 
evidence for some neurotoxicity signs such as 
lack of concentration, loss of memory, dis-
turbed sleep, impaired balance, mood disor-
ders, and irritability in humans after indoor 
exposure to FA by inhalation. Otherwise, the 
ingestion of FA was accompanied by severe 
symptoms such as lethargy, seizures, and loss 
of consciousness (Burkhart et al., 1990). 
Low-level exposure to FA resulted in an im-
mediate restless behavior with noticeable mo-
tor disabilities in rats (Boja et al., 1985). In 
addition, mice submitted to 13 week-exposure 
at 40 ppm exhibited dyspnea and ataxia (Mar-
onpot et al., 1986). A recent report has 
pointed out the possible onset of anxiety- and 
depression-like behaviors along with cogni-
tive impairments in mice exposed to low 
doses of inhaled FA for one week (Li et al., 
2016). On the other hand, discrepant findings 
have been reported in experimental animals 
regarding the hematotoxic and immunotoxic 
outcomes of FA. In both male and female 
Sprague-Dawley rats, no hematocrit or hemo-
globin level changes were found after a 90-
day exposure to a relatively high dose (Mar-
onpot et al., 1986). In male Wistar rats, Var-
gova et al. (1993) indicated a significant in-
crease in hematocrit, erythrocyte count, and 
hemoglobin, and a decline in mean corpuscu-
lar hemoglobin concentration following a 4-
week FA gavage at 40-80 mg/kg. Orally ad-
ministered or inhaled doses have also been 
shown to alter the antibody responses in ro-
dents, exacerbating, therefore, the overall 
pathological sequelae of FA exposure (Abd-
Elhakim et al., 2016; Sapmaz et al., 2016). 
However, the current research efforts pay lit-
tle attention to the neurobehavioral and 
hemato-immune aspects of FA toxicity during 
pregnancy. Hence, it would be well worth in-
vestigating whether gestational FA exposure 
can lead to maternal changes in these aspects, 
which may, in turn, contribute to FA-induced 
fetotoxicity. 
Nowadays, the search for natural medi-
cines with potential health benefits against a 
variety of toxic agents is on trial. A substan-
tial interest is particularly devoted to as-
sessing the preventive effects of bioflavo-
noids that are widely available for dietary in-
take in humans. Hesperidin (HP) (hesperetin-
7-rutinoside), one of the most biologically ac-
tive compounds in the flavonoid family, is a 
flavanone glycoside found at high levels in 
citrus fruits such as lemons, limes, and or-
anges. It has been reported to exhibit a wide 
range of pharmacological effects, including 
anticarcinogenic, anti-inflammatory and anti-
oxidant activities (Garg et al., 2001). Recent 
toxicological studies have highlighted the 
strong ability of HP to protect various tissues 
against the oxidative injuries caused by toxic 
agents (Çetin et al., 2016; Siddiqi et al., 
2015). This bioflavonoid was also proven to 
alleviate the hemato-immune toxicity induced 
by a chronic oral exposure to diazinon in rats 
(Hassouna et al., 2015) and restore the ac-
quired immune activities in irradiated mice 
(Lee et al., 2011). Furthermore, neuroprotec-
tive and cognitive-enhancing effects of HP 
were demonstrated in a murine model of alu-
minum-induced neurotoxicity (Jangra et al., 
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2015). However, to our knowledge, no previ-
ous studies describing the perigestational in-
take of HP in intoxicated rodents were per-
formed. The aforementioned findings of HP 
properties prompt us to explore its effective-
ness in counteracting FA-related toxicity in 
pregnant dams and their fetuses. 
This study aims to investigate the ability 
of perigestational treatment with HP to pre-
vent the pathological changes in maternal be-
havioral, hemato-immune and hormonal pa-
rameters as well as in fetal growth signs fol-
lowing FA oral exposure in rats. 
 
MATERIALS AND METHODS 
Animals and housing 
Three-month-old male and female Wistar 
rats, obtained from Pasteur Institute, were 
group-housed (4-5 per cage for each sex) in 
transparent polyethylene cages (58 × 39 × 
19 cm) in a temperature-controlled room (23 
± 1 °C). The rats were maintained on a 12-
h/12-h light cycle (lights on at 07:30 a.m.) 
with access to standard rodent chow and tap 
water ad libitum. The experimental protocol 
was carried out according to the NIH revised 
Guidelines for the Care and Use of Labora-
tory Animals (No. 80-23, 1996). 
 
Drugs 
Hesperidin (≥ 80 % purity powder; 
Sigma-Aldrich Co., Saint Louis, USA) was 
dissolved in distilled water and freshly admin-
istered by gavage at 50 mg/kg of body weight. 
The formaldehyde solution (37 %; Sigma-Al-
drich Co., Saint Louis, USA) was prepared in 
distilled water and freshly administered by 
gavage at 2 mg/kg of body weight. Both hes-
peridin and formaldehyde were provided to 
animals in a volume of 1 ml/kg of body 
weight. 
 
Experimental procedure 
After two weeks of acclimatization to the 
laboratory conditions, forty-four (44) female 
rats weighing approximately 200 ± 10 g were 
randomly chosen and housed individually in 
transparent polyethylene cages (44 × 28 × 
15 cm). They were allotted to four groups (n 
= 11): vehicle-treated control rats (C), hesper-
idin-treated rats (HP), formaldehyde-exposed 
rats (FA), and formaldehyde-exposed rats 
pretreated with hesperidin (HP-FA). Rats of 
each group were subjected to their first vagi-
nal smear to determine estrus cycle phases us-
ing a standard cytological analysis (Freeman, 
1994). Proestrus females received vehicle 
(groups C and FA) or HP (groups HP and HP-
FA) at 09:00 a.m. Two hours later, they were 
treated with either vehicle (groups C and HP) 
or FA (groups FA and HP-FA). Both HP and 
FA were administered for ten (10) consecu-
tive days (i.e. two estrus cycles) before mat-
ing. At the end of this phase, rats were sub-
jected to the second vaginal smears, and each 
proestrus female was mated overnight with 
one sexually experienced male, without any 
interruption of the pharmacological admin-
istration. The presence of sperm plugs in the 
vaginal smears 12 hrs later indicated the first 
day of conception. Both HP and FA treat-
ments were then continued until GD19. The 
body weight was measured daily in all preg-
nant females from GD1 to GD19. 
At GD1, GD10 and GD19, a set of 
twenty-four (24) pregnant rats (six per group) 
were submitted to a behavioral assessment us-
ing the elevated plus-maze and open field 
tasks, to determine their anxiety-like and ex-
ploratory behaviors, then excluded from the 
experiment. The remaining twenty (20) preg-
nant rats (5 rats per group) were left undis-
turbed (except for body weight measurement) 
until GD19, at which they were decapitated 
under mild ether anesthesia. Trunk blood was 
collected in ethylenediaminetetraacetic acid 
(EDTA)-coated tubes to evaluate the hemato-
immune status. Plasma samples were properly 
conserved and used to appraise the hormonal 
profile. 
 
Behavioral assessment 
Elevated plus-maze test (EPM) 
The EPM apparatus consisted of two open 
arms (50 x 10 cm) and two closed arms (50 x 
10 × 45 cm) extending from a central platform 
(10 x 10 cm) and elevated 50 cm above the 
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floor (Patin et al., 2005). A 3-5 mm high rail-
ing was added around the perimeter of the 
open arms to prevent rats from falling off the 
maze. The test room was lit by a 60-W electric 
bulb hanging directly 175 cm above the cen-
tral area of the maze (Estanislau and Morato, 
2005). Each rat was placed individually in the 
center of the apparatus facing one open arm 
and allowed to explore the maze for 5 min. 
The animals' behavior was videotaped and 
then analyzed using SMART computer soft-
ware (v3.0.04., Panlab S.L.U., Spain). Upon 
completion of the task, the rat was returned to 
its home cage, and the maze was cleaned with 
an alcoholic solution followed by wet and dry 
paper towels, before the next trial. 
Open field test (OF) 
As previously described (Sáenz et al., 
2006), the OF apparatus consisted of a gray 
square arena (70 x 70 x 40 cm) with the floor 
divided into 16 equal quadrants by black 
painted lines. The test room was dimly illumi-
nated by a red bulb (25 W) located 130 cm 
from the center of the arena under the same 
environmental conditions as the colony room. 
Each rat was placed individually in the center 
of the OF, for a free exploration of 5 minutes. 
The animals' activities were videotaped and 
recorded using SMART computer software 
(v3.0.04., Panlab S.L.U., Spain). After each 
test, the rat was removed from the arena by 
the experimenter and returned to the home 
cage, and the apparatus was cleaned with an 
alcoholic solution followed by wet and dry 
paper towels, to avoid transfer of olfactory 
cues between animals. 
Hemato-immune analysis 
Blood analysis was carried out using an 
automated cell counter (PCE-210 model 
2009, Japan). Eleven parameters were meas-
ured at the same time: white blood cells 
(WBC), the number and percentage of lym-
phocytes (LYM), the number and percentage 
of monocytes (MONO), the number and per-
centage of granulocytes (GRAN), red blood 
cells (RBC), hemoglobin (HGB), hematocrit 
(HCT) and platelets (PLT). 
 
Hormonal analysis 
Plasma levels of cortisol, 17β-estradiol 
(E2) and progesterone (P4) were determined 
by the electrochemiluminescence immunoas-
say (ECLIA) method using an automated an-
alyzer according to the manufacturer’s in-
structions (Cobas e-411 analyzer, Roche Di-
agnostics, Germany). 
 
Fetal examination 
Upon sacrifice, the abdominal cavities 
were opened and the uteri were dissected out. 
The uterine horns were checked for the num-
ber of live and resorbed fetuses. Live (non-re-
sorbed) fetuses and their placentas were care-
fully taken and weighed. The following mor-
phometric parameters were measured: the 
cranial perimeter, the abdominal perimeter, 
the crown-rump length, the elbow-paw 
length, the foot length and the tail length. An 
external examination was thereafter per-
formed to reveal any fetal malformations. 
 
Statistical analyses 
All results are expressed as the mean ± 
SEM (Standard Error of the Mean). One-way 
analysis of variance (ANOVA) was used for 
multiple comparisons, followed by the 
Tukey–Kramer’s post-hoc test when neces-
sary. Two-way ANOVA (treatment × time) 
was used for behavioral tests. A linear regres-
sion analysis was applied on the maternal 
body weight gain. The value of p<0.05 was 
considered as the significant difference. Data 
were analyzed using the Minitab software 
(version 17.1.0.0., Minitab Ltd., UK). 
 
RESULTS 
Body weight gain 
Figure 1 depicts the regression of dams' 
body weight versus the gestational days. A 
linear relationship between weight and days 
was observed. In the FA-treated group, for 
each increase in a gestation day, the weight of 
the rats enhances, on the average, by 1.253 g. 
However, in controls, it increases by 3.329 g. 
Interestingly, HP supplementation in FA-
treated rats remarkably ameliorates the 
weight gain, which increases by 2.511 g.
EXCLI Journal 2017;16:400-413 – ISSN 1611-2156 
Received: January 14, 2017, accepted: March 14, 2017, published: March 30, 2017 
 
 
404 
 
Figure 1: Hesperidin effect on body weight gain in FA-exposed pregnant rats. C (Control), HP (Hesper-
idin), FA (Formaldehyde), HP-FA (Formaldehyde-exposed rats pretreated with Hesperidin) 
 
 
Anxiety-like and exploratory behaviors in 
the EPM 
Figure 2 illustrates the rats' behavior in the 
EPM test. Two-way ANOVA revealed signif-
icant effects of treatment, time and treatment 
× time interaction (p<0.001) on all parame-
ters. At GD1, HP, FA, and HP-FA groups 
spent shorter time in closed arms (p<0.001, 
p<0.01 and p<0.001, respectively), and 
greater time in both open arms (p<0.001, 
p<0.01 and p<0.001, respectively) and central 
area (p<0.05, p<0.01 and p<0.05, respec-
tively) as compared to controls. Additionally, 
when compared to HP group, FA- and HP-
FA-treated rats spent less time in the open 
arms (p<0.001 and p<0.01, respectively), and 
greater time in closed ones (p<0.001 and 
p<0.01, respectively). However, only FA-ex-
posed rats spent higher time in the central 
zone (p<0.01). HP administration in FA-
treated dams significantly enhanced the time 
spent in open arms (p<0.001) while decreas-
ing the time spent in both closed arms 
(p<0.001) and central area (p<0.05) as com-
pared to FA group. On the other hand, FA 
treatment significantly declined the distance 
traveled in the EPM as compared to C and HP 
groups (p<0.001 and p<0.01, respectively). 
HP supplementation in FA-exposed rats sig-
nificantly enhanced the distance traveled in 
the apparatus (p<0.001) as compared to that 
in FA group. At GD10, HP and FA treatments 
significantly decreased the time spent in both 
open arms (p<0.001 and p<0.05, respec-
tively), and central area (p<0.001 and p<0.01 
respectively), and the distance traveled in the 
EPM (p<0.001 and p<0.01, respectively), 
whereas, they increased the time spent in 
closed arms (p<0.001 and p<0.05 respec-
tively) as compared to controls. Furthermore, 
FA- and HP-FA-treated rats spent greater 
time in the open arms (p<0.05 and p<0.001, 
respectively), and shorter time in closed ones 
(p<0.05 and p<0.001, respectively), and trav-
eled a longer distance in the apparatus 
(p<0.001) as compared to HP group. HP-FA-
treated dams spent lesser time in the open 
arms (p<0.05) when compared to controls and 
longer time in the central zone (p<0.001) as 
compared to HP group. On the other hand, 
they spent a shorter time in closed arms 
(p<0.05) and greater time in the central area 
(p<0.01), and traveled a longer distance in the 
EPM (p<0.001) when compared to FA-ex-
posed rats. At GD19, HP, FA and HP-FA 
treatments significantly declined the time 
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spent in open arms (p<0.001, p<0.01 and 
p<0.01, respectively), and central zone 
(p<0.001) and the distance traveled in the ap-
paratus (p<0.001), however, they enhanced 
the time spent in closed arms (p<0.001) as 
compared to controls. Interestingly, the FA-
treated rats spent a shorter time in closed arms 
(p<0.05) and traveled a longer distance in the 
EPM (p<0.001) when compared to HP group. 
HP-FA dams spent greater time in the open 
arms (p<0.05) as compared to HP ones and 
traveled lesser distance in the apparatus 
(p<0.001) when compared to FA group. 
 
Anxiety-like and exploratory behaviors in 
the OF 
The rats' behavior in the open field is pre-
sented in Figure 3. Two-way ANOVA regis-
tered significant effects of time (p<0.001) and 
treatment × time interaction (p<0.01) on total 
time spent in both peripheral and central ar-
eas. Furthermore, it showed significant ef-
fects of treatment (p<0.001) on the average 
duration of rearing, and of treatment, time, 
and treatment × time interaction (p<0.001) on 
the distance traveled in the arena. At GD1, HP 
and FA rats traveled lesser distance in the OF 
(p<0.01) as compared to controls. Moreover, 
FA exposure significantly decreased the aver-
age duration of rearing as compared to C, HP 
and HP-FA groups (p<0.01, p<0.001 and 
p<0.01, respectively). HP-FA treatment sig-
nificantly increased the distance traveled in 
the apparatus when compared to both HP and 
FA groups (p<0.001 and p<0.01, respec-
tively). At GD10, when compared to controls, 
HP and HP-FA treatments significantly de-
clined the distance traveled in the OF 
(p<0.001 and p<0.01, respectively). Besides, 
the average duration of rearing significantly 
decreased in FA-treated rats (p<0.01) as com-
pared to vehicle- and HP-treated rats. Moreo-
ver, FA and HP-FA  treatments  significantly 
 
Figure 2: Hesperidin effect on elevated plus-maze parameters in FA-exposed pregnant rats. C (Con-
trol), HP (Hesperidin), FA (Formaldehyde), HP-FA (Formaldehyde-exposed rats pretreated with Hes-
peridin). a p<0.05, b p<0.01, and c p<0.001 versus C group; α p<0.05, β p<0.01, and γ p<0.001 versus 
HP group; * p<0.05, ¶ p<0.01, and, # p<0.001 versus FA group 
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enhanced the distance traveled in the arena 
(p<0.001) as compared to HP group. Addi-
tionally, HP-FA-treated dams traveled higher 
distance in the OF (p<0.001) when compared 
to FA group. At GD19, HP- and HP-FA-ex-
posed rats traveled less distance in the appa-
ratus (p<0.001) as compared to controls. FA 
exposure significantly decreased the distance 
traveled in the OF when compared to both C 
and HP groups (p<0.05 and p<0.001 respec-
tively). Furthermore, HP-FA dams exhibited 
greater time in the center and shorter time in 
the peripheral area when compared to FA-
treated rats (p<0.01). On the other hand, HP-
FA treatment significantly declined the trav-
eled distance in the OF (p<0.001) as com-
pared to both C and FA groups. Interestingly, 
the average duration of rearing significantly 
declined in FA- and HP-FA-treated animals 
when compared to both C (p<0.001 and 
p<0.01, respectively) and HP (p<0.001) 
groups. 
Hemato-immune parameters 
Table 1 shows the hemato-immune pa-
rameters in the control and treated groups. 
Compared to controls, total leukocyte count 
significantly decreased in all treated rats be-
longing to HP, FA and HP-FA groups 
(p<0.01, p<0.05 and p<0.001, respectively), 
with the lowest level registered in HP-FA rats 
(p<0.001) as compared to FA ones. Signifi-
cant lymphopenia was observed in HP 
(p<0.05), FA and HP-FA (p<0.01) dams com-
pared to C group. The nadir was noticed in 
HP-FA animals (p<0.01) when compared to 
FA ones. The percentage of lymphocytes de-
creased significantly in FA (p<0.01) and HP-
FA (p<0.05) groups when compared to con-
trols, with the lowest point depicted in FA-
treated dams (p<0.05) as compared to HP 
ones. Moreover, the mean monocyte values 
depleted significantly in HP (p<0.01), FA and 
HP-FA (p<0.001) groups when compared to 
 
 
Figure 3: Hesperidin effect on open field parameters in FA-exposed pregnant rats. C (Control), HP 
(Hesperidin), FA (Formaldehyde), HP-FA (Formaldehyde-exposed rats pretreated with Hesperidin). a 
p<0.05, b p<0.01, and c p<0.001 versus C group; β p<0.01 and γ p<0.001 versus HP group; ¶ p<0.01 
and # p<0.001 versus FA group 
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Table 1: Hesperidin effect on hemato-immune parameters in FA-exposed pregnant rats 
Parameters 
Groups 
C HP FA HP-FA 
WBC (× 103/dl) 8.65 ± 0.49 6.70 ± 0.17 b 6.20 ± 0.58 a 5.05 ± 0.08 c,γ 
LYM (× 103/dl) 5.05 ± 0.43 3.85 ± 0.20 a 3.10 ± 0.29 b 2.65 ± 0.08 b,β 
MONO (× 103/dl) 1.45 ± 0.03 1.10 ± 0.05 b 0.95 ± 0.03 c 0.85 ± 0.03 c,β,* 
GRAN (× 103/dl) 2.15 ± 0.03 1.75 ± 0.03 c 2.20 ± 0.23 1.55 ± 0.03 c,β,* 
LYM (%) 58.70 ± 2.08 56.30 ± 1.73 49.90 ± 0.29 b,α 52.10 ± 0.98 a 
MONO (%) 15.90 ± 0.86 16.35 ± 1.30 15.20 ± 0.69 16.65 ± 1.18 
GRAN (%) 25.40 ± 1.21 27.35 ± 0.43 34.90 ± 0.40 c,γ 31.70 ± 0.46 b,γ,¶ 
RBC (× 106/µl) 8.01 ± 0.09 7.00 ± 0.02 c 7.02 ± 0.06 c 7.91 ± 0.008 γ,# 
HGB (g/dl) 14.35 ± 0.03 12.40 ± 0.06 c 11.15 ± 0.03 c,γ 14.25 ± 0.03 a,γ,# 
HCT (%) 45.55 ± 0.32 39.20 ± 0.06 c 37.80 ± 0.63 c 42.75 ± 0.08 c,γ,# 
PLT (× 103/dl) 137.0 ± 4.62 112.0 ± 2.89 b 42.0 ± 3.46 c,γ 80.0 ± 3.46 c,γ,# 
Data are reported as mean ± SEM (n=5). 
WBC: white blood cells, LYM: lymphocytes, MONO: monocytes, GRAN: granulocytes, RBC: red blood cells, HGB: hemoglobin, 
HCT: hematocrit, PLT: platelets. C (Control), HP (Hesperidin), FA (Formaldehyde), HP-FA (Formaldehyde-exposed rats pre-
treated with Hesperidin). a p<0.05, b p<0.01, and c p<0.001 versus C group; α p<0.05, β p<0.01, and γ p<0.001 versus HP group; 
* p<0.05, ¶ p<0.01, and, # p<0.001 versus FA group 
 
 
controls, with the nadir noticed in HP-FA rats 
as compared to both HP (p<0.01) and FA 
(p<0.05) ones. The granulocyte levels de-
creased significantly in HP- and HP-FA-ex-
posed dams (p<0.001) when compared to 
controls, with further decrease in HP-FA ani-
mals as compared to both HP and FA groups 
(p<0.01 and p<0.05, respectively). However, 
the percentage of granulocytes increased sig-
nificantly in FA- and HP-FA-treated rats 
when compared to both controls (p<0.001 and 
p<0.01 respectively) and HP group 
(p<0.001), with the highest level registered in 
FA dams (p<0.01) as compared to HP-FA 
ones. HP and FA treatments significantly de-
pleted the RBC count (p<0.001) when com-
pared to control group. On the contrary, HP-
FA treatment significantly enhanced RBC 
levels (p<0.001) as compared to both HP and 
FA dams. Interestingly, hemoglobin concen-
tration significantly depleted in HP, FA 
(p<0.001) and HP-FA (p<0.05) groups when 
compared to controls. The nadir was noticed 
in FA-exposed rats (p<0.001) as compared to 
HP and HP-FA groups, whereas the highest 
point, was observed in HP-FA dams 
(p<0.001) when compared to FA ones. Simi-
larly, hematocrit level significantly decreased 
in all treated groups (p<0.001) when com-
pared to controls, with a remarkable rise in 
HP-FA-exposed dams (p<0.001) as compared 
to HP- and FA-treated ones. Likewise, plate-
lets significantly declined in HP (p<0.01), FA 
and HP-FA (p<0.001) groups when compared 
to controls. The nadirs were depicted in FA- 
and HP-FA-treated rats (p<0.001) as com-
pared to HP-ones, with the lowest point regis-
tered in FA group (p<0.001) when compared 
to HP-FA one. 
 
Hormonal concentrations 
Table 2 depicts the hormonal changes in 
the different groups of pregnant rats. Cortisol 
concentration significantly increased in FA- 
and HP-FA-treated dams when compared to 
both controls and HP-treated ones (p<0.001), 
with a higher level in FA group as compared 
to HP-FA one (p<0.001). Moreover, HP sig-
nificantly enhanced the E2 concentration 
(p<0.01), and FA reduced its level (p<0.001) 
when compared to controls. Additionally, 
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FA- and HP-FA-treated rats showed a signif-
icant decrease in the E2 level (p<0.001 and 
p<0.01 respectively) as compared to HP 
group, with the lowest point registered in FA 
rats (p<0.001) when compared to HP-FA 
ones. Furthermore, no statistically significant 
result was noticed in respect of progesterone 
concentration between all groups. 
 
Fetal parameters 
Table 3 demonstrates the fetal parameters 
in the control and treated rats. FA- and HP-
FA-treated dams exhibited a lower number of 
the live fetuses (p<0.001) and consequently a 
higher number of the resorbed ones as com-
pared to controls (p<0.001) and HP group 
(p<0.001 and p<0.01, respectively). HP ad-
ministration in FA-exposed animals slightly 
enhanced the number of live fetuses 
(p<0.001) and reduced the number of resorp-
tion (p<0.01) when compared to FA group. 
Moreover, the placental weight significantly 
decreased in FA- and HP-FA-administered 
dams (p<0.05) as compared to vehicle-treated 
ones. The fetal body weight significantly in-
creased in HP-treated rats (p<0.05) when 
compared to controls, while decreasing in 
FA- and HP-FA-exposed dams as compared 
to both controls (p<0.001 and p<0.05, respec-
tively) and HP group (p<0.001 and p<0.01, 
respectively), with further decrease in FA-
treated rats (p<0.01) compared to HP-FA 
group. Furthermore, FA exposure signifi-
cantly reduced the cranial and abdominal pe-
rimeters as compared to controls (p<0.05 and 
p<0.001, respectively), HP and HP-FA 
(p<0.01) groups. The abdominal perimeter re-
mains decreased in HP-FA fetuses (p<0.05) 
when compared to controls. FA treatment sig-
nificantly depleted the crown-rump and el-
bow-paw lengths as compared to C (p<0.01 
and p<0.05, respectively), HP and HP-FA 
(p<0.05) groups. Additionally, FA and HP-
FA treatments significantly reduced the foot 
length (p<0.001 and p<0.05, respectively) 
when compared to C and HP groups, with the 
lowest value registered in FA fetuses (p<0.05) 
as compared to HP-FA ones. Similarly, FA 
and HP-FA treatments significantly depleted 
the tail length when compared to both C 
(p<0.01) and HP (p<0.001 and p<0.01, re-
spectively) groups. No external malfor-
mations were found in the fetuses of the 
treated dams as compared to the control group 
(Figure 4). 
 
DISCUSSION 
The present study investigates the poten-
tial ability of hesperidin to counteract the 
pathophysiological outcomes of perigesta-
tional exposure to FA. Our results show that 
FA reduced the maternal weight gain. This re-
duction was accompanied by a significant 
hormonal imbalance on GD19. Cortisol levels 
were elevated, whereas E2 rates were declined 
in FA-exposed rats compared to control coun-
terparts. Recently, a considerable weight loss 
has been registered in Sprague-Dawley male 
rats exposed to a relatively low dose of FA 
(5.27 ± 0.24 ppm) by inhalation, which might 
be due to a lack of appetite (Aydin et al., 
2015). Repetitive exposure to toxic com-
pounds is considered as a chemical stress, 
which activates the hypothalamic-pituitary-
adrenal (HPA) axis and leads to high secret- 
 
 
Table 2: Hesperidin effect on plasma cortisol, 17β-estradiol (E2) and progesterone (P4) levels in FA-
exposed pregnant rats 
Hormones 
Groups 
C HP FA HP-FA 
Cortisol (µg/dl) 1.22 ± 0.10 1.31 ± 0.11 6.61 ± 0.38 c,γ 3.55 ± 0.30 c,γ,# 
E2 (pg/ml) 36.41 ± 0.76 42.63 ± 1.29 b 24.19 ± 0.58 c,γ 33.43 ± 1.17 β,# 
P4 (ng/ml) 62.41 ± 2.44 60.26 ± 1.24 58.15 ± 1.19 59.48 ± 1.22 
Data are reported as mean ± SEM (n=5). 
b p<0.01 and c p<0.001 versus C group; β p<0.01 and γ p<0.001 versus HP group; # p<0.001 versus FA group. 
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Table 3: Hesperidin effect on fetal parameters in FA-exposed pregnant rats 
Parameters 
Groups 
C HP FA HP-FA 
Number of live fetuses 
per litter 11.50 ± 0.64 9.75 ± 0.48 1.50 ± 0.29 c,γ 4.75 ± 0.48 c,γ,# 
Number of resorbed fe-
tuses per litter 0.00 ± 0.00 0.50 ± 0.29 4.25 ± 0.48 c,γ 2.25 ± 0.25 c,β,¶ 
Placental weight (g) 0.54 ± 0.02 0.51 ± 0.06 0.40 ± 0.03 a 0.44 ± 0.02 a 
Fetal body weight (g) 3.46 ± 0.11 4.21 ± 0.22 a 2.00 ± 0.05 c,γ 2.96 ± 0.16 a,β,¶ 
Cranial perimeter (mm) 34.25 ± 1.89 40.25 ± 2.50 26.75 ± 1.38 a,β 34.00 ± 1.08 ¶ 
Abdominal perimeter 
(mm) 46.00 ± 1.68 45.25 ± 2.29 32.75 ± 1.11 c,β 39.00 ± 1.29 a,¶ 
Crown-Rump length (mm) 31.00 ± 0.91 30.50 ± 1.55 23.50 ± 1.55 b,α 29.25 ± 0.85 * 
Elbow-Paw length (mm) 8.00 ± 0.41 8.25 ± 0.75 6.00 ± 0.41 a,α 7.50 ± 0.29 * 
Foot length (mm) 13.00 ± 0.41 13.50 ± 0.64 9.00 ± 0.41 c,γ 11.25 ± 0.48 a,α,*
Tail length (mm) 15.75 ± 0.48 16.75 ± 0.48 11.50 ± 0.64 b,γ 13.25 ± 0.48 b,β 
Data are reported as mean ± SEM. 
a p<0.05, b p<0.01, and c p<0.001 versus C group; α p<0.05, β p<0.01, and γ p<0.001 versus HP group; * p<0.05, ¶ p<0.01, 
and, # p<0.001 versus FA group. 
 
 
 
Figure 4: Photographs of rat fetuses from the dif-
ferent groups on gestational day 19. A: Fetus from 
C group. B: Fetus from HP group. C: Fetus from 
FA group. D: Fetus from HP-FA group. 
 
ion of cortisol from the adrenal glands (Fried-
man and Lawrence, 2002). It has been re-
ported that the stereotypical stress response 
includes suppression of appetite and food in-
take in about 30 % of human subjects (Stone 
and Brownell, 1994). The concomitant de-
crease in E2 levels following gestational ex-
posure to FA seems to be paradoxical because 
of lower E2 levels cause hyperphagia and en-
hance body weight gain (Butera, 2010). Alt-
hough the feeding behavior was not evaluated 
in our study, the maternal stress response to 
FA toxicity is likely to overwhelm the over-
eating effect of low E2 rates. In fact, under 
such stress circumstances, energy ensuing 
from overeating can be diverted to physiolog-
ical activities aiming to eliminate the toxic 
agents and reestablish homeostasis, resulting 
in a body weight loss (Yau and Potenza, 
2013). On the other hand, we found that the 
treatment with HP alone significantly en-
hanced E2 levels and caused a noticeable de-
crease in maternal body weight as compared 
to controls. However, in combination with ex-
posure to FA, the treatment was able to stabi-
lize the body weight gain approximately at the 
level of HP-supplemented rats. Previous stud-
ies have stated that flavonoids can modulate 
estrogen rates in humans by interacting with 
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the activity of key enzymes in estrogen bio-
synthesis, such as 17 beta-hydroxy steroid de-
hydrogenases (Jacobs and Lewis, 2002), and 
high E2 rates were associated with food rejec-
tion during pregnancy in non-human primates 
(Czaja, 1975). Our findings indicate that HP 
might cause anorexia in pregnant rats through 
the rise of E2 circulating levels, leading to a 
remarkable decrease in body weight. In HP-
FA animals, the treatment with this flavanone 
reduced cortisol levels while enhancing E2 
ones, alleviating, therefore, the stress re-
sponse and leading apparently to a hormonal 
equilibrium for the sake of a better weight 
gain as compared to FA-exposed counter-
parts. 
Rats submitted to daily exposure to FA 
exhibited anxiety-like behavior and locomo-
tive disabilities. The anxiety signs were seen 
in the EPM test only as the gestational state 
progresses (i.e. GD10 and 19). On GD1, FA-
exposed animals spent a longer time in both 
the open arms and the central square area, and 
a shorter time in the closed arms of EPM com-
pared to their control counterparts. In the OF 
test, no difference between FA-exposed and 
control rats was found throughout the gesta-
tional period regarding the time spent in both 
central and peripheral areas. These two latest 
findings, which may erroneously be inter-
preted as a reduced anxiety, are actually due 
to a disorientation as revealed by the lower 
average duration of rearings (Fursenko et al., 
2016). On the contrary, the locomotive disa-
bilities caused by FA were obviously found in 
both EPM and OF tests as indicated by the de-
creased distance traveled. It is generally 
known that anxiety disorders are related to 
disorientation, whereas lethargy is one of the 
main symptoms of sickness behavior (Barra-
clough, 1997; Ridder et al., 2011). These cog-
nitive impairments have been linked to either 
high cortisol or lower E2 levels in different 
neuropsychiatric contexts (Kritz-Silverstein 
and Barrett-Connor, 2002; Lara et al., 2013; 
Sherwin, 1996). Our results speculate that FA 
toxicity may cause a brain damage and lead to 
emotional and cognitive deficits in pregnant 
rats. The treatment with HP produced an an-
xiolytic action in the EPM particularly on 
GD1, and at a lesser extent on GD10 by af-
fecting the time spent in closed arms and cen-
tral square area. A significant amelioration of 
locomotion was also registered in HP-FA an-
imals on GD1 in the OF test, and on GD1 and 
10 for the EPM test. It is noteworthy that the 
anxiolytic effect of HP was found here to be 
masked by its sedative property obviously 
seen on GD10 and 19 in the EPM, and at all 
gestational timepoints in the OF, as demon-
strated by the decreased distance traveled in 
both behavioral paradigms. Oral treatment 
with HP (50 and 100 mg/kg) for two weeks 
was reported to elicit anxiolytic and locomo-
tive-enhancing effects in immobilization-
stressed mice (Viswanatha et al., 2012). Nev-
ertheless, HP has repeatedly found to exhibit 
a strong sedative impact in mice (Loscalzo et 
al., 2008; Martínez et al., 2009). Therefore, 
our findings suggest that the anxiolytic effi-
cacy of HP can be hidden by its sedative re-
percussion as the treatment progresses, which 
is correlated with the evolving FA-related 
sickness behavior in pregnant rats. 
The hemato-immune status showed a sig-
nificant decline in almost all parameters fol-
lowing both FA exposure and HP treatment. 
In FA-exposed rats, the absolute GRAN and 
relative MONO counts were not affected, but 
the relative GRAN count was increased. In 
HP-treated rats without FA exposure, no 
change in relative LYM, MONO, and GRAN 
counts was found. We further noticed that the 
effect of FA was stronger in decreasing HGB 
and PLT measures than HP. The administra-
tion of HP in FA-exposed animals was effi-
cient in alleviating RBC, RGB, HCT, PLT 
and relative GRAN counts, but failed to re-
store WBC, LYM, MONO, GRAN, relative 
LYM and relative MONO measures. The 
ability of FA to alter the hematopoietic func-
tion was mentioned in several studies, though 
the data on this hematotoxicity are incon-
sistent. Exposure to this toxic agent was found 
to reduce WBC counts in humans (Kuo et al., 
1997). A more detailed study concluded that 
the immune profile of exposed workers shows 
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increased B cells, but decreased total T cells 
(CD3) and T-suppressor cells (CD8), with no 
significant change in T-helper cells (CD4) 
(Ye et al., 2005). High-dose exposure to FA 
in male rats was also reported to enhance 
RBC, MONO, and HGB measures while de-
creasing LYM counts (Vargova et al., 1993). 
In our study, the immunosuppressing effect of 
FA could also be attributed to hypercorti-
solemia. Contrariwise, the lowering effect of 
HP on the hemato-immune status may be 
linked to the high E2 levels. Both stromal and 
hematopoietic cells in the bone marrow abun-
dantly express estrogen receptors (ERs) 
(Smithson et al., 1995, 1998), and the sup-
pression of some hematopoietic lineages has 
been revealed in estrogen-treated adult mice 
(Medina and Kincade, 1994; Medina et al., 
2000). Interestingly, HP supplementation in 
FA-exposed rats significantly restored the he-
matological part of the hemato-immune sta-
tus, but failed to relieve the immunotoxicity, 
except for the relative GRAN count, despite 
the considerable attenuation of cortisol levels. 
These findings reflect the detrimental impact 
of FA on the immune system and highlight the 
complex HP-FA interactions to reduce tox-
icity in pregnant rats. 
A significant reproductive failure was 
also noticed in FA-exposed pregnant rats. Fe-
tal body weight and morphometric measures 
were considerably lower than those registered 
in control and HP-supplemented counterparts. 
The placental weight was also decreased by 
FA toxicity compared to control animals. Alt-
hough no teratological defects were found, an 
extremely high resorption rate was revealed, 
leading to a very low number of live fetuses 
per litter in FA-exposed rats. It was recently 
reported in pregnant Balb/C mice that expo-
sure to FA during organogenesis induces 
toxic changes in the placental structure and 
functions, causing a considerable decrease in 
fetal weights (Monfared, 2014). Nevertheless, 
our findings further indicate that these repro-
ductive deficits are probably related to FA-in-
duced hormonal changes because HP co-ad-
ministration, by regulating the hormonal sta-
tus, was able to alleviate almost all develop-
mental parameters without restoring the pla-
cental weight to control levels. To our 
knowledge, there are no published data about 
the interference of HP supplementation with 
toxic repercussions of FA exposure in preg-
nant subjects.  
Our study showed that perigestational ex-
posure to FA was associated with various tox-
icological aspects in rats. Significant changes 
in hormonal (except for P4 rates) and hemato-
immune profiles, along with a decrease in 
body weight gain and a behavioral alteration 
(anxiety- and lethargy-like signs, disorienta-
tion and locomotor disabilities), were found 
in dams. Severe developmental deficits were 
also registered in FA-exposed offspring at 
GD19, as indicated by lower fetal body 
weight, fetal morphometric measures, and 
placental weight as well as by higher resorp-
tion rates. However, no fetal external malfor-
mations were seen. Co-administration of HP 
was able to sustain the maternal body weight 
gain and regulate the hormonal status while 
alleviating FA-induced hematological de-
cline. However, the immunotoxicity caused 
by FA was not relieved by HP treatment. The 
anxiolytic and motor-enhancing effects of HP 
were revealed at GD1 and 10 but hidden later 
by a strong sedative impact, which might 
evolve as the treatment duration progresses. 
In the offspring, the treatment with HP miti-
gated FA-induced developmental deficits 
without affecting the placental weight. It is 
noteworthy that, besides a sedative effect, HP 
supplementation was accompanied by higher 
E2 plasma levels in the positive control ani-
mals (group HP), with no adverse repercus-
sions on both dams and offspring. Similar in-
vestigations are needed to further evaluate the 
potential beneficial role of HP in counteract-
ing FA toxicity during pregnancy. 
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